This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

C-Erbb-2 Positive

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What C-Erbb-2 Positive Means

C-Erbb-2 positive, also called HER2 positive or human epidermal growth factor receptor 2 positive, refers to cancer cells that have more of a protein called HER2 on their surface than normal cells. HER2 is a protein that helps cells grow and divide in a controlled way. When cancer cells have too much HER2, they can grow faster and spread more easily to other parts of the body.

Why HER2 Status Matters in Cancer Care

Knowing whether a cancer is c-erbB-2 positive helps doctors understand how the cancer might behave. It also helps guide treatment decisions. Some cancers with extra HER2 respond well to targeted therapies designed to block HER2’s effects. These treatments can slow cancer growth or help kill cancer cells that have too much HER2. HER2 positivity is most often discussed in breast cancer but can also be found in bladder, pancreatic, ovarian, stomach, and esophageal cancers.

What Patients Might See or Hear About C-Erbb-2 Positive

You might hear your care team say your cancer is HER2 positive or c-erbB-2 positive. This usually comes from tests done on a biopsy or tumor sample. The results may appear in pathology reports, treatment plans, or discussions about clinical trials and drug options. Understanding your HER2 status is one important part of planning your care.

What C-Erbb-2 Positive Does Not Automatically Mean

Having HER2-positive cancer does not automatically mean your cancer is more dangerous or that your treatment will be the same as others with HER2-positive cancer. It is one factor among many that doctors consider. Not all cancers have high HER2 levels, so testing is necessary to know your specific situation.

How Doctors Use HER2 Status in Treatment Planning

Doctors test tumor samples to check HER2 levels to decide if targeted therapies against HER2 might be helpful. These treatments are designed to attack cancer cells with too much HER2. HER2 status is part of a larger picture that includes other tests and factors to plan your care.

Understanding Different Names and Avoiding Confusion

The terms c-erbB-2, HER2, HER2/Neu, and human epidermal growth factor receptor 2 all refer to the same protein. Seeing different names can be confusing, but they mean the same thing. It helps to ask your care team to explain what your test results mean for your treatment.

Questions to Ask Your Care Team

If you hear about HER2 or c-erbB-2, you might ask: What does being HER2 positive mean for my cancer? Are there treatments that target HER2? How will this affect my treatment plan and follow-up care? Your healthcare team can help you understand how this information fits into your overall care.

Remembering the Purpose of This Information

This information is educational and does not replace personalized medical advice. Each person’s cancer is unique, and treatment decisions depend on many factors. If you have questions about HER2 or how it relates to your care, talking openly with your healthcare team is the best next step. They can explain what your test results mean and guide you through your treatment choices.

Sources

Public source information used for this glossary entry includes: